Eventide Gilead Class N ETGLX

Medalist Rating as of | See Eventide Investment Hub
  • NAV / 1-Day Return 62.49  /  −1.53 %
  • Total Assets 3.2B
  • Adj. Expense Ratio
    1.380%
  • Expense Ratio 1.380%
  • Distribution Fee Level High
  • Share Class Type No Load
  • Category Mid-Cap Growth
  • Investment Style Mid Growth
  • Min. Initial Investment 1,000
  • Status Open
  • TTM Yield 0.00
  • Turnover 60%

USD | NAV as of Jun 17, 2026 | 1-Day Return as of Jun 17, 2026, 12:43 AM GMT+0

Morningstar’s Analysis ETGLX

Will ETGLX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

Navigating some challenges.

Director Andrew Daniels

Andrew Daniels

Director

Summary

Despite personnel turnover of late, Eventide Gilead remains a decent offering at the right price. Recent adjustments to some share classes’ Morningstar Medalists Ratings don’t reflect a shift in conviction in the team or approach but instead result from Morningstar’s revised method for calculating excess return opportunities.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings ETGLX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 32.7
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Guardant Health Inc

5.53 148M
Healthcare

Xometry Inc Ordinary Shares - Class A

4.35 117M
Industrials

Lam Research Corp

4.13 111M
Technology

Us Bank Mmda - Usbgfs 9

3.88 104M
Cash and Equivalents

ASML Holding NV ADR

3.23 87M
Technology

Trane Technologies PLC Class A

2.95 79M
Industrials

Old Dominion Freight Line Inc Ordinary Shares

2.85 76M
Industrials

Scholar Rock Holding Corp

2.68 72M
Healthcare

Mirum Pharmaceuticals Inc

2.44 66M
Healthcare

Toast Inc Class A

2.32 62M
Technology

Sponsor Center